Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Apr 28
 -0.13 / -1.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 15.50, with a high estimate of 45.00 and a low estimate of 8.00. The median estimate represents a +67.57% increase from the last price of 9.25.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Valeant Pharmaceuticals. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.77%
Growthannually -29.44%


Growthquarterly -8.41%
Growthannually -9.01%
Key to the earnings and sales forecast charts.